Last updated: 2026-09-16 09:05:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
GLOBUS MEDICAL INC. (GMED) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $74.79, with a market capitalisation of $10.17B and a P/E ratio of 18.73. Over the past 52 weeks, its price has ranged from $54.15 to $101.40. This page covers its latest market performance, valuation, price trends and company information.
$10.17B | |
$74.70 | |
$101.40 | |
$10.26 | |
$74.69 | |
2.18K | |
1.60M | |
18.73 | |
$101.40 | |
$54.15 | |
-- | |
-- |
GLOBUS MEDICAL INC. (GMED) is trading at $74.79 in pre-market trading as of 2026-09-16 08:56:00, up 0.14% ($0.10) from the previous close of $74.69
Pre-market trading shows how investors are pricing GMED before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, GLOBUS MEDICAL INC. (GMED) moved from $78.29 to $74.79, representing a decline of 4.47% ($3.50).
The stock traded between $72.84 and $78.69 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 1.63 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 43.7%
GMED is currently trading at $74.79, placing it 43.7% of the way from its 52-week low of $54.15 to its 52-week high of $101.40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 6000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of GLOBUS MEDICAL INC. (GMED) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.